Pharmaceutical company Bristol will buy MyoKardia for $ 13.1 billion

News

Pharmaceutical company Bristol will buy MyoKardia for $ 13.1 billion

07.10.2020 News

The American pharmaceutical company Bristol-Myers Squibb announced that it will buy biotech MyoKardia for $ 13.1 billion. Quotes of the MyoKardia at the previous trading increased by 59%.

Bristol will pay $ 225 for each share of the MyoKardia, corresponding to 61% premium to the value of the company’s securities at the close of trading on Friday ($ 139.6 per piece).

The agreement will allow for the Bristol to gain the control of the experimental drug MyoKardia for heart disease, which, if approved, will give the company the opportunity to reduce its dependence on the cancer therapy. Drugs in this area accounted for more than $ 16 billion of the approximately $ 20 billion in the revenue that Bristol received in the first half of this year.

Mavacamten drug treats the chronic heart disease, which can lead to the heart of the rhythm disturbances in some patients and even to the death.

Sales of the drug in the world may exceed $ 1.5 billion by 2025, writes The Wall Street Journal with the reference to the forecast of analysts BMO Capital Markets.

Bristol plans to get the approval for the use of the drug from the US health regulators next year, said the head of the company Giovanni Caforio. Bristol is counting on its approval with the acquisition of the MyoKardia, which will allow it to expand its portfolio of the heart disease drugs.

Other articles

Read also

Pharmaceutical company Bristol will buy MyoKardia for $ 13.1 billion
News

Lifecell sold towers to the Ukrainian sister company for $ 52 million

Mobile operator lifecell sold its sister company telecommunication towers in Ukraine.  The Ukrtower Company will pay minimum $ 52 million plus taxes for  811 objects. This is stated in the message of the owner of the company – Turkish Turkcell Holding. According to the report, the resolution on the transaction was carried by the Turkish […]

Next
Pharmaceutical company Bristol will buy MyoKardia for $ 13.1 billion
News

The price of oil exceeded $ 44 on news from the United States

World oil prices of reference brands continue to rise on the news of the victory of the Democratic candidate Joe Biden in the US presidential election and information on the success of tests of the vaccine from COVID-19 of the American company Pfizer Inc. and German BioNTech. This is evidenced by trading data on Wednesday, […]

Next
Pharmaceutical company Bristol will buy MyoKardia for $ 13.1 billion
News

US pharmaceutical giant Pfizer will open a new hub in Greece

American Pfizer is one of the world’s largest pharmaceutical companies. Greek government spokesman Stelios Petsas stated it’s expanding its presence in Greece, creating 600 workplaces. Pfizer’s chairman is Greek Albert Burla. In recent months, the company has been developing a vaccine against coronavirus. A company hub opens in Thessaloniki. “Greece is attracting big investment and […]

Next
Pharmaceutical company Bristol will buy MyoKardia for $ 13.1 billion
News

Tesla to sign the pact with Grohmann Engineering next year

The Tesla Motors will conclude the bargain with the  Grohmann Engineering GmbH complex. The representatives of the American company which are engaged in a construction of electro cars intend to redeem 100% of  the systems European developer shares  for batteries release. They are going to  close the deal until the end of 2017. The cooperation […]

Next
Pharmaceutical company Bristol will buy MyoKardia for $ 13.1 billion
News

Intel announced a breakthrough in transistor technology that will enhance the performance of the new chips by 20%

At the annual press conference as part of “Architecture Day 2020”, Intel has announced improvements in the production of new graphics processors for laptops, PCs and server processors. Positive news was received in not the best time for the company Intel, since July 23, after the close of Thursday, shares fell by more than 20%, […]

Next
Pharmaceutical company Bristol will buy MyoKardia for $ 13.1 billion
News

Rating of the best countries for business: what has Ukraine achieved?

For the year Ukraine dropped 13 points lower in the world ranking by business publication Forbes «Best Countries for Business”: from 61 to 74 place. According to the research, which included the analysis of the basic conditions for doing business in different countries of the world, since the beginning of 2016 Ukraine’s index dropped significantly. […]

Next
Pharmaceutical company Bristol will buy MyoKardia for $ 13.1 billion
News

Does Ukraine refuse to continue oil business in Egypt?

Company Naftohaz  Ukraine has analyzed the alternatives to  sale the foreign assets, but there is no a buyer for it. According to the director of the company  Andrii Kobolev, the true reason for this is a low profitability of Ukrainian Naftohaz assets in Egypt. It is reported by UNIAN. Kobolev said that it is not […]

Next
Pharmaceutical company Bristol will buy MyoKardia for $ 13.1 billion
News

The Japanese are buying one of the largest IT employers in Ukraine

Japanese company Hitachi has announced the purchase of American developer GlobalLogic for $ 9.6 billion, according to Reuters. The American company has several offices in Ukraine and is one of the three largest IT employers in the country. GlobalLogic owns 45% in equal shares of Canada Pension Plan Investment Board and Swiss investment company Partners […]

Next
Pharmaceutical company Bristol will buy MyoKardia for $ 13.1 billion
News

Events under the Verkhovna Rada: “Lawyers – are practically the most intellectual … well, the fool always takes by force …”

A lawyer — is a peaceable profession which is designed to protect. Both violations of the rights of lawyers and depreciation of institute of legal profession completely level the rights of the citizen of Ukraine. Under such slogan the peaceful protest action of lawyers under walls of the Verkhovna Rada took place, devoted to fighting […]

Next
Pharmaceutical company Bristol will buy MyoKardia for $ 13.1 billion
News

L’Oreal has created a virtual make-up for video conferences

The French company has developed an augmented reality application for digital makeup. The Signature Faces application allows you to apply filters to your face in real time. “We believe that everyone is beautiful by themselves, but in a world where the camera is always on, it’s normal to want to “play” with filters. We want […]

Next
Pharmaceutical company Bristol will buy MyoKardia for $ 13.1 billion
News

The Ukrainian investment company Digital Future co-invested $ 13.1 million in the startup of YouAppi in the round

The Digital Future Investment company became a co-investor in the startup YouAppi round “B”. According to the CEO of the Digital Future,  Alexei Vitchenko, this  is the first transaction of the Ukrainian investment company  in the “B” round level. The deposit amount is not disclosed. American-Israel YouAppi service was founded in 2011. YouAppi technology is […]

Next
Pharmaceutical company Bristol will buy MyoKardia for $ 13.1 billion
News

Netflix’s future growth will come from India and other major Asian markets

Shares of Netflix fell after the company released a quarterly report on October 20 with only 2.2 million new subscribers. At the same time, over the last week, stock growth has resumed and since the beginning of the year, the share price of Netflix has risen by 59%. The company’s management and analysts cited the […]

Next
Pharmaceutical company Bristol will buy MyoKardia for $ 13.1 billion
News

Thermo Fisher merges with the Affymetrix company

The largest manufacturer of equipment for laboratory research Thermo Fisher, conclude a purchase deal to buy the Affymetrix company, which develops integrated solutions for genetic researches, for $ 1.3 billion cash. Following the announcement of the transaction, shares of the Affymetrix company sharply increased in price by 50%. Currently, Thermo Fisher estimates Affymetrix estimates at […]

Next
Pharmaceutical company Bristol will buy MyoKardia for $ 13.1 billion
News

The Billionaire Bill Ackman sold 5 million shares of Valeant Pharmaceuticals to cover tax losses

Bill Ackman, the owner of the Pershing Square Capital Management investment firm recently announced that he sold 5 million shares in a major pharmaceutical company Valeant Pharmaceuticals. Thus,  his part fell from 9.9% to 8.5%. In an official statement, which was provided by the USA regulatory authorities stated that the sale aims to cover tax […]

Next
Pharmaceutical company Bristol will buy MyoKardia for $ 13.1 billion
News

Robinhood in June surpassed all brokers by number of deals

Startup company in the brokerage industry of the Robinhood on Monday for the first time published their monthly trade data platform. Robinhood Markets is a discount brokerage company that has become popular with novice investors, which offers commission-free trading through its website and mobile app. One of the key indicators which used in the brokerage […]

Next
Pharmaceutical company Bristol will buy MyoKardia for $ 13.1 billion
News

Ukrainian startup TripMyDream was acknowledged as the best travel-startup in the world and will receive investments up to $ 500,000

In Lausanne (the Swiss city) took place  the final of the international start-up competition Seedstars Summit 2016 in which the best tourist startup in the world was chosen. The main prize, the investment of up to $ 500,000 received the Ukrainian company TripMyDream. The team fought for the title of winner among the ten finalists, […]

Next
WP2Social Auto Publish Powered By : XYZScripts.com